Discover deeper molecular insights by adding the SomaScan Assay to your mass spectrometry analysis

Learn more about high-plex protein profiling at US HUPO 2024 in Portland, Oregon.

Join us at booth 208 at US HUPO 2024 —
March 9-13, 2024

Mark your calendars for a special breakfast seminar presented by Towia Libermann, PhD, Beth Israel Deaconess Medical Center, on Monday, March 11.

Our scientists will present recent data at their poster sessions. And the rest of our team will be at booth 208. Stop by to learn how you can access HALF the genetically encoded human proteome with the new SomaScan 11K Assay – enabling 11,000 protein measurements with unparalleled reproducibility and specificity.

Full details for all our events are below.

Towia Libermann, PhD


Comprehensive proteomics using the SomaScan® 11K Assay: Identification of biomarkers for differential diagnosis of inflammatory bowel disease subtypes and prediction of therapeutic response to biologics

Monday, March 11  |  7:15-8:15 a.m.  |  Location: Multnomah Room (Level 1)

Presenter: Towia Libermann, PhD

  • Associate Professor of Medicine
  • Director, BIDMC Genomics, Proteomics, Bioinformatics, and Systems Biology Center
  • Director, DF/HCC Cancer Proteomics Core
  • Div. of Interdisciplinary Medicine and Biotechnology
  • Beth Israel Deaconess Medical Center

Dr. Libermann’s team has been using the SomaScan Platform to discover diagnostic serum and mucosal biopsy biomarkers capable of differentiating between pediatric Crohn’s disease (CD) and ulcerative colitis (UC), as well as UC with and without primary sclerosing cholangitis (PSC).

In a multicenter, prospective trial of children treated with the TNF inhibitor infliximab, they identified serum proteins that are highly associated with response to infliximab and accurately predict response prior to treatment.

See more data and talk to our scientists at their poster sessions

Date and Time Session Title
Monday, March 11
9:35-10:55 a.m.
Oral Presentation
Adding Genomics to Highly Multiplex Proteomics for Improved Predictive Modeling Performance
Monday, March 11
1:30-3:00 p.m.
Optimizing Biomarker Discovery with Focus on Low Coefficient of Variation in Large-Scale Proteomics
Tuesday, March 12
1:30-3:00 p.m.
A Method for Modeling Proteome Dynamics in Unbalanced Longitudinal Datasets and Improve Biomarker Discovery

Want to learn more about the advantages of adding the SomaScan Assay to your mass spectrometry analysis?

See published findings